Weiss Multi-Strategy Advisers’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
Other funds holding TXMD
CWG
RCMNY
Weiss Multi-Strategy Advisers's TXMD Position: Q1 2022 in Review
Weiss Multi-Strategy Advisers sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 3,328 shares — an estimated $59K sold.
Weiss Multi-Strategy Advisers first reported a position in TXMD in Q3 2015 and held it in 18 quarters. The position peaked at $530K in Q3 2019. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.
- Weiss Multi-Strategy Advisers reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
- Weiss Multi-Strategy Advisers sold 3,328 TherapeuticsMD shares in Q1 2022, an estimated $59K.
- Weiss Multi-Strategy Advisers first reported a position in TherapeuticsMD in Q3 2015 and held it in 18 quarters.
- Weiss Multi-Strategy Advisers's TherapeuticsMD position peaked at $530K in Q3 2019.
- 124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2022, filed 16 May 2022.